Smart implant fights swelling to boost hearing

NCT ID NCT06598059

Ongoing Disease control Sponsor: Cochlear Source: ClinicalTrials.gov ↗

Summary

This study is testing a new type of cochlear implant designed to slowly release a common anti-inflammatory drug (dexamethasone) into the inner ear after surgery. The goal is to see if reducing swelling and tissue damage helps the implant work better at improving hearing. The study involves 56 adults with severe to profound hearing loss who will receive the experimental implant and have their hearing tested over several months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Henry Ford Health

Detroit, Michigan, 48202, United States
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
NYU Langone Health

New York, New York, 10017, United States
New York Eye and Ear Infirmary

New York, New York, 10010, United States
Northwell Health Long Island Jewish Medical Center

New York, New York, 11042, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Rocky Mountain Ear Center

Englewood, Colorado, 80113, United States
UCLA Medical Center

Los Angeles, California, 90095, United States
University Hospitals

Cleveland, Ohio, 44106, United States
University of Iowa

Iowa City, Iowa, 52242, United States
Washington University

St Louis, Missouri, 63141, United States

Conditions

Explore the condition pages connected to this study.

HEARING LOSS